Výsledky vyhledávání - Jacqueline Nicholas
- Zobrazuji výsledky 1 - 8 z 8
-
1
-
2
Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis Autor Jacqueline Nicholas, Natalie C. Edwards, Roger Edwards, Anna Dellarole, Megan Grosso, Amy Phillips
Vydáno 2020Revisão -
3
Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database Autor Aaron Boster, Jacqueline Nicholas, Ning Wu, Wei‐Shi Yeh, Monica Fay, Michael Edwards, Ming‐Yi Huang, Andrew Lee
Vydáno 2017Artigo -
4
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US Autor Daniel Ontaneda, Jacqueline Nicholas, Matthew Carraro, Jia Zhou, Qiang Hou, Jaanai Babb, Katherine Riester, Jason P. Mendoza, Terrie Livingston, Mehul Jhaveri
Vydáno 2018Artigo -
5
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years Autor Stephen L. Hauser, Anne H. Cross, Kevin Winthrop, Heinz Wiendl, Jacqueline Nicholas, Sven G. Meuth, Paul S. Giacomini, Francesco Saccà, Linda Mancione, Ronald Zielman, Morten Bagger, Ayan Das Gupta, Dieter A. Häring, Valentine Jehl, Bernd C. Kieseier, Ratnakar Pingili, Dee Stoneman, Wendy Su, Roman Willi, Ludwig Kappos
Vydáno 2022Artigo -
6
Associations of<scp>sNfL</scp>with clinico‐radiological measures in a large<scp>MS</scp>population Autor Elias S. Sotirchos, Kathryn C. Fitzgerald, Carol M. Singh, Matthew D. Smith, Maria Reyes‐Mantilla, Carrie M. Hersh, Megan Hyland, Ryan Canissario, Sarah B. Simmons, Georgina Arrambide, Xavier Montalbán, Manuel Comabella, Robert T. Naismith, Min Qiao, Lauren Krupp, Jacqueline Nicholas, Katja Akgün, Tjalf Ziemssen, Richard A. Rudick, Elizabeth Fisher, Robert Bermel, Ellen M. Mowry, Peter A. Calabresi
Vydáno 2022Artigo -
7
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) Autor Ellen M. Mowry, Robert Bermel, James R. Williams, Tammie L.S. Benzinger, Carl de Moor, Elizabeth Fisher, Carrie M. Hersh, Megan Hyland, Izlem Izbudak, Stephen E. Jones, Bernd C. Kieseier, Hagen H. Kitzler, Lauren Krupp, Yvonne W. Lui, Xavier Montalbán, Robert T. Naismith, Jacqueline Nicholas, Fabio Pellegrini, Àlex Rovira, Maximilian Schulze, Björn Tackenberg, Mar Tintoré, Madalina E. Tivarus, Tjalf Ziemssen, Richard A. Rudick
Vydáno 2020Artigo -
8
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study Autor Amit Bar‐Or, Heinz Wiendl, Xavier Montalbán, Enríque Alvarez, M. V. Davydovskaya, Silvia Delgado, Evgeniy Evdoshenko, Nataša Giedraitienė, Katrin Gross‐Paju, Sulev Haldre, Craig Herrman, Guillermo Izquierdo, Guntis Karelis, Fritz Leutmezer, Miroslav Mareš, José Meca-Lallana, Dalia Mickevičienė, Jacqueline Nicholas, Derrick Robertson, Д В Сазонов, Kenneth Sharlin, Bharathy Sundaram, N. А. Totolyan, Marta Vachová, Martin Vališ, Morten Bagger, Dieter A. Häring, Inga Ludwig, Roman Willi, Martin Zalesak, Wendy Su, Martin Merschhemke, Edward Fox
Vydáno 2021Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Multiple sclerosis
Immunology
Fingolimod
Environmental health
Population
Teriflunomide
Adverse effect
Confidence interval
Dimethyl fumarate
Disease
Family medicine
Lymphoma
Meta-analysis
Ofatumumab
Rituximab
Tolerability
Atrophy
Bioequivalence
Cmax
Cohort
Computer science
Cumulative incidence
Discontinuation
Economic growth
Economics
Engineering
Expanded Disability Status Scale
Gastroenterology